Alzheimer’s disease: The right drug, the right time

G&D mobile
Drs. Todd Golde (left) and Steven DeKosky.

MBI director Todd Golde, M.D., Ph.D. and MBI deputy director Steven DeKosky, M.D., collaborated for a perspective paper published in the journal Science titled “Alzheimer’s disease: The right drug, the right time.”

The paper highlights how lessons from failed clinical trials can improve the development of Alzheimer’s disease-modifying therapies.

“We must continue to build a more predictive, translational road map and adhere to the principles of good drug development to ensure that efforts from basic science translated to clinical trial design meet the challenges of treatment and prevention.”

Click here to read the paper in Science.